Fundraising FoxPreceptis Medical
Golden Valley, US · Founded 2011 · Delaware corporation · 3 known investors
Find your way into Preceptis Medical
Sign up to see every warm intro you have to Preceptis Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Preceptis Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JD
Joe DelgadoCFO / GM Healthcare Services (Reimbursement and Market Access)2018–2025Joe Delgado is an Executive Officer at Preceptis Medical and brings experience in strategy, product development, and corporate roles spanning healthcare services, IT, insurance, and provider organizations, with background in business development, product management, and M&A.
TB
Toni BaragaExecutive
Board
FJ
Feng JiangBoard director
BB
Buzz BensonBoard director
CG
Christopher GeyenBoard director
DO
David OvermanBoard director
ZY
Zhaohua YuanBoard director
ML
Michael LoushinBoard director
TV
Thomas VettelBoard director
MD
Michael DaleChairman of the Board of Directors2011–2016President, Chief Executive Officer and Board Director at Axogeninc
Investors · 3
Also in the syndicate · 1
Montesy Helen (HK) Limitedlead
Reported raises · per SEC filings
Form D private placements$22.4M disclosed across 9 of 10 rounds · 2014–2026
▶$2.6MraisedMay 2026 · 27 investors · Other Health CareRule 506(b)
▶$2.6MraisedMay 2026 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Greg Van GuilderDirector
- Buzz BensonDirector
- David OvermanDirector
- Christopher GeyenDirector
- Michael LoushinDirector
- John SeabergDirector
- David CareyExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $2.6M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJan 2025 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedJan 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael LoushinDirector
- Feng JiangDirector
- Steve AndersonExecutive Officer, Director
- Buzz BensonDirector
- Joe DelgadoExecutive Officer
- Christopher GeyenDirector
- David OvermanDirector
- Zhaohua YuanDirector
- John SeabergExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2M
- Sales commissions
- $117K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedFeb 2023 · 2 investors · Other Health CareRule 506(b)
▶$4.5MraisedFeb 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Zhaohua YuanDirector
- Feng JiangDirector
- Michael LoushinDirector
- Steve AndersonExecutive Officer, Director
- David OvermanDirector
- Christopher GeyenDirector
- John SeabergExecutive Officer, Director
- Buzz BensonDirector
- Joe DelgadoExecutive Officer
- Offering amount
- $7M
- Amount sold
- $4.5M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.9MraisedFeb 2021 · 20 investors · Other Health CareRule 506(b)
▶$3.9MraisedFeb 2021 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve AndersonExecutive Officer, Director
- Michael LoushinDirector
- Christopher GeyenDirector
- David OvermanDirector
- Joe DelgadoExecutive Officer
- John SeabergExecutive Officer, Director
- Feng JiangDirector
- Zhaohua YuanDirector
- Buzz BensonDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedMar 2020 · 26 investors · Other Health CareRule 506(b)
▶$3.7MraisedMar 2020 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve AndersonExecutive Officer, Director
- Michael LoushinDirector
- Christopher GeyenDirector
- David OvermanDirector
- Joe DelgadoExecutive Officer
- John SeabergExecutive Officer, Director
- Feng JiangDirector
- Zhaohua YuanDirector
- Buzz BensonDirector
- Offering amount
- $9M
- Amount sold
- $3.7M
- Sales commissions
- $455K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$376.9KraisedDec 2017 · 78 investors · Other Health CareRule 506(b)
▶$376.9KraisedDec 2017 · 78 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher GeyenDirector
- Toni BaragaExecutive Officer
- Steve AndersonExecutive Officer, Director
- Buzz BensonDirector
- John SeabergExecutive Officer, Director
- Michael LoushinDirector
- David OvermanDirector
- Offering amount
- $384.4K
- Amount sold
- $376.9K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MofferedAug 2017 · Other Health CareRule 506(b)
▶$1MofferedAug 2017 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher GeyenDirector
- Mark WagnerDirector
- David OvermanDirector
- Michael LoushinDirector
- Steve AndersonExecutive Officer, Director
- Offering amount
- $1M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$90KraisedJun 2016 · 3 investors · Other Health CareRule 506(b)
▶$90KraisedJun 2016 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael DaleDirector, Promoter
- Mark WagnerDirector
- Thomas VettelDirector, Promoter
- Michael LoushinDirector, Promoter
- Steve AndersonExecutive Officer, Director, Promoter
- Toni BaragaExecutive Officer
- Offering amount
- $3M
- Amount sold
- $90K
- Sales commissions
- $200K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Preceptis Medical's investors?
- Preceptis Medical's investors include EFung Capital, Heuristic Capital Partners.
- How much funding has Preceptis Medical raised?
- Preceptis Medical has disclosed $22.4M raised across 9 of its 10 known rounds.
- Where is Preceptis Medical headquartered?
- Preceptis Medical is headquartered in Golden Valley, US.